Fig. 6

Analysis of lncRNA risk score in clear cell renal cell carcinoma (ccRCC) patients. a The entire set (530 tumor samples). b The training set (265 tumor samples). c The validation set (265 tumor samples). Each panel consists of three rows: top row, the low- and high-score group for the lncRNA signature in ccRCC patients; middle row, the survival status and duration of ccRCC cases; bottom row, heatmap showing the expression of the six key lncRNAs. The color, from blue to red shows, low to high expression, respectively